Lupus (SLE): nyitott vizsgálatok itt: Kanada

19 nyitott vizsgálatnak van helyszíne itt: Kanada. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT07355218
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.
The Medical Arts Health Research Group - 300128547, Kelowna
Regiszter frissítve: 2026-11-04
NCT05039619
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Kísérleti kezelés · 2. fázis · Hoffmann-La Roche
Hospital Sainte-Justine, Montreal · The Hospital for Sick Children, Toronto
Regiszter frissítve: 2026-11-03
NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Kísérleti kezelés · 3. fázis · UCB Biopharma SRL
Sl0044 50771, Québec · Sl0044 50259, Rimouski · Sl0044 50045, Toronto
Regiszter frissítve: 2026-11-02
NCT07085104
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Kísérleti kezelés · 1. fázis · Allogene Therapeutics
Hôpital Maisonneuve-Rosemont, Montreal
Regiszter frissítve: 2026-11-02
NCT07175285
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Kutatás · Bristol-Myers Squibb
Alberta Health Services (AHS) - Richmond Road Diagnostic and Treatment Centre, Calgary · Centre hospitalier de l'Université Laval, Calgary · St. Joseph's Hospital, London · The Ottawa Hospital - General Campus, Ottawa · Sherbrooke · Toronto Western Hospital, Toronto
Regiszter frissítve: 2026-11-02
NCT07691970
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Kísérleti kezelés · 3. fázis · AstraZeneca
Québec
Regiszter frissítve: 2026-10-28
NCT06916806
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Kísérleti kezelés · 1. fázis · AstraZeneca
Hamilton · Sherbrooke
Regiszter frissítve: 2026-10-19
NCT04976322
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Kísérleti kezelés · 3. fázis · UCB Biopharma SRL
Sl0046 50374, Calgary · Sl0046 50337, Edmonton AB · Sl0046 50259, Rimouski · Sl0046 50045, Toronto
Regiszter frissítve: 2026-10-15
NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals
Rimouski · Toronto · Vancouver
Regiszter frissítve: 2026-10-13
NCT06121297
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Kísérleti kezelés · 1/2. fázis · Cabaletta Bio
Maisonneuve-Rosemont Hospital, Montreal
Regiszter frissítve: 2026-10-06
NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Kísérleti kezelés · 1. fázis · National Cancer Institute (NCI)
University Health Network, Princess Margaret Hospital, Toronto
Regiszter frissítve: 2026-10-05
NCT05352919
A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
Kísérleti kezelés · 3. fázis · Biogen
Toronto Western Hospital, Toronto
Regiszter frissítve: 2026-10-05
NCT05835310
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Kísérleti kezelés · 3. fázis · AstraZeneca
Calgary · Toronto · Vancouver
Regiszter frissítve: 2026-09-30
NCT07038447
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
Kísérleti kezelés · 1. fázis · Kite, A Gilead Company
Jewish General Hospital, Montreal · The Ottawa Hospital - General Campus, Ottawa
Regiszter frissítve: 2026-09-28
NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Kísérleti kezelés · 3. fázis · AstraZeneca
Calgary · Hamilton · Richmond · Toronto · Winnipeg
Regiszter frissítve: 2026-09-25
NCT06897930
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Kísérleti kezelés · 1/2. fázis · AstraZeneca
Toronto
Regiszter frissítve: 2026-09-10
NCT00198068
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Kutatás · Hospital for Special Surgery, New York
Ez a vizsgálat csak várandós résztvevőket keres
Mt Sinai Hospital, Toronto
Regiszter frissítve: 2026-04-28
NCT05934149
Lupus Landmark Study: A Prospective Registry and Biorepository
Kutatás · Lupus Research Alliance
University Of Calgary, Calgary · University of Alberta Hospital, Edmonton · McGill University Health Centre, Montreal · CHU de Quebec-Universite Laval, Québec · University Health Network-Toronto Western Hospital, Toronto · University of Manitoba, Winnipeg
Regiszter frissítve: 2026-04-15
NCT06232304
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Kísérleti kezelés · Michigan State University
The Hospital for Sick Children, Toronto
Regiszter frissítve: 2025-10-30

Minden vizsgálat (Lupus (SLE)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek